GlobeNewswire Inc.··NaLantheus Shifts Strategy, Posts $1.54B in 2025 Revenue Amid Pipeline Expansion
Lantheus posted $1.54B in 2025 revenue but faces Q4 headwinds. The company plans to refocus on PET diagnostics while exploring options for radiotherapy assets, expecting four FDA approvals in 2026.
LNTHearningsacquisitions